Shenzhen Kangning Hospital
11
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
An Implementation Study of Suicide Risk Management Among Discharged Psychiatric Patients
Role: lead
TEEM-GIFTS: A Gamified mHealth to Reduce Post-Discharge Suicide Risk
Role: lead
Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease
Role: collaborator
Software-delivered CBT-I for Insomnia Disorder
Role: collaborator
Threat Reversal Abnormality in Patients With Anxiety Disorders
Role: lead
Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes
Role: collaborator
Reconsolidation-Based Intervention for Traumatic Memories
Role: lead
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
Role: collaborator
Effects of Subconscious Memory Extinction in Patients With Alcohol Dependence and Its Mechanism
Role: lead
Clinical Study of Ligustrazine in Treating Alcohol Addiction
Role: lead
Effect of Orexin System on Nicotine Addiction and Its Neural Mechanism
Role: lead
All 11 trials loaded